European AIDS Treatment Group

EU Legislative Interests

- EU Pharmaceutical Strategy - Timely patient access to affordable medicines : consultation on the roadmap and strategy: EATG submission and via European Public Health Alliance as members. Previous input/submissions: - COMMISSION STAFF WORKING DOCUMENT SWD(2018) 387 final on Combatting HIV/AIDS, viral hepatitis and tuberculosis in the European Union and neighbouring countries - State of play, policy instruments and good practices - Submission to EMA Consultation on the Role of big data for evaluation and supervision of medicines in the EU - Submission to EU Drugs Strategy 2013-20 – evaluation consultation(December 2019-Feb 2020);

Communication Activities

EATG contributed to EU-level coordination and advocacy through the EU Civil Society Forum on HIV, TB and Hepatitis, working in coordination with AAE, EHRA, Correlations and TBEC. EATG also engaged with the WHO/Europe Pan-European Mental Health Coalition, launched to address gaps in mental health services and support, many of which were worsened by the COVID-19 pandemic. EATG continued to support the Glasgow Manifesto of the International Coalition of Older People with HIV (iCOPe HIV), launched at the Glasgow HIV Conference in October 2022 and endorsed by over 150 organisations. iCOPe HIV is an initiative of the founding partners EATG (Europe), NATAP (USA), Realize (Canada) and UTOPIA_BXL (Belgium). EATG contributed to major projects addressing inequalities, prevention and research inclusion, including RBDCOV (RBD dimer recombinant protein vaccine against SARS-CoV-2), and Project CORE (2023–2025), which aims to reduce inequalities by promoting, strengthening and integrating community responses that are key to reaching people not yet connected to prevention and healthcare services, especially in Member States where such responses remain limited. EATG also supported the Strategic Community HIV Prevention Empowerment (SCOPE) project, which strengthens community engagement at local and regional levels to reduce gaps in access to HIV combination prevention among populations most affected by HIV but still underserved and underrepresented in policy and public debate. In research and policy, EATG contributed to Project PROMise, aiming to develop guidance and recommendations for the use of HIV-specific Patient Reported Outcome Measures (PROMs) in HIV R&D in collaboration with community organisations, academia, industry, regulators and Health Technology Assessment bodies. EATG also advanced Project BELONG, producing a position paper advocating for the inclusion of people living with HIV in clinical research across Europe, aligned with FDA guidance and calling for regulation by the EMA not only in cancer trials but across disease areas. EATG endorsed a series of letters and statements addressing EU health policy, access to medicines, funding and human rights. It also submitted a response to the public consultation on Intergenerational Fairness, advocating for measures to ensure the right to health for people of all ages. EATG contributed to policy input on gender inequalities in health (2025/2074(INI)), including Action 4.4 to address gaps in data availability and quality by disaggregating data by sex, gender and age, and improving data on access to PrEP. Under Strategic Priority 5 (EU Neighbourhood), EATG highlighted the importance of upscaling HIV prevention in the EU’s neighbourhood, including dedicated funding through the Instrument for Pre-accession Assistance (IPA). The principle of leaving no one behind is especially relevant for candidate countries such as Moldova and Ukraine, which remain among the countries with the highest rates of new HIV infections (ECDC, 2024). Together with the HIV Prevention Alliance, EATG called on the European Commission (DG ENEST) to ensure dedicated IPA funding to upscale combination HIV prevention services in candidate countries (Action 5.1). Under Strategic Priority 6 (Global Health), EATG supported EU action to prevent a deteriorating global HIV epidemic through health security and international partnerships, aligned with the European Council Strategic Agenda 2024–29 and the Sustainable Development Goals. With the HIV Prevention Alliance, EATG called on the European Commission (DG HERA) to ensure a clear focus on HIV prevention within EU health security and preparedness (Action 6.1), and urged EU institutions to dedicate funding within the current EU budget and the next MFF to reinforce international cooperation on HIV through EU partnerships (Action 6.2).

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

EU Civil Society Forum (CSF) on HIV , TB and Hepatitis EU Civil Society Forum on Drugs WHO Regional Coordination Committee on HIV, TB and Hep AIDS Action Europe EACS European AIDS Clinical Society European Forum for Good Clinical Practice (EFGCP) European Patient Forum (EPF) Platform for Cooperation with undocumented migrants (PICUM) ILGA – Europe ESWA - European Sex Workers Rights Alliance HIV Outcomes Europe HIV Prevention Alliance HIV Justice Network

Organisation Members

https://www.eatg.org/partners/